- 中文名稱
【干冰】人I型干擾素中和抗體混合物
- 英文名字
- Human Type I Interferon Neutralizing Antibody Mixture
- 供應(yīng)商
- PBL Assay Science
- 產(chǎn)品貨號
- PBL-39000-1
- 產(chǎn)品報(bào)價(jià)
- ￥詢價(jià)/0.2ml
- 產(chǎn)品說明書
- 點(diǎn)擊查看
- 購買方式
- 銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金，在線支付寶及網(wǎng)銀支付，或直接與我們電話聯(lián)系400-6800-868。
- 產(chǎn)品新聞
- 背景資料
- PBL Assay Science提供各種干擾素亞型的蛋白，抗體和檢測試劑盒，如：IFN-Alpha（IFN-ɑ 2a，IFN-ɑ 2b，IFN-ɑ 5，IFN-ɑ 6，IFN-ɑ 7，IFN-ɑ 14，IFN-ɑ 16，IFN-ɑ 17......），IFN-Beta（IFN-β 1a，IFN-β 1b），IFN-Lambda（IFN-λ），IFN-Omega（IFN-ω），IFN-Gamma（IFN-γ）......
- 應(yīng)用類型
- 中和作用
- 免疫原
- 來源宿主
- 反應(yīng)性
- 人
- 保存建議
- -20?C/-70°C
- 其他
- 部分文獻(xiàn)：
n1、On, K-S. et al., (2024), "Immunomodulatory effects of trastuzumab derustecah through the cGAS-STING pathway in gastric cancer cells", Cell Commun Signal, 22(1):518, PMID: 39449023, DOI: 10.1186/s12964-024-01893-3
n2、Ishibashi, H. K. et al., (2024), "TLR3 signaling-induced interferon-stimulated gene 56 plays a role in the pathogenesis of rheumatoid arthritis", Exp Biol Med., 249:10122, PMID: 38881847, DOI: 10.3389/ebm.2024.10122
n3、Lee, A. & Nathan. C, (2024), "Type I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death", EMBO Rep. PMID: 38866980, DOI: 10.1038/s44319-024-00171-0 n4、Geoffroy, K. et al., (2024), "Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer", Molecular Therapy: Oncology, DOI; 10.1016/j.omton.2024.200826
n5、Lim, H. A. et al., (2023), "Innate antiviral responses against Shaan virus infection in HEK293, A549 and MARC-145 cells and limited role of viperin against Shaan virus replication", Heliyon, 9:e22597, DOI: 10.1016/j.heliyon.2023.e22597
n6、Tabtieng, T. et al., (2022), "Caspase-Mediated Regulation and Cellular Heterogeneity of the cGAS/STING Pathway in Kaposi's Sarcoma-Associated Herpesvirus Infection", mBio, e:0244622, PMID: 36255240, DOI: 10.1128/mbio.02446-22
n7、Tsuji, S. et al., (2022), "SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response", Nature Aging, DOI: 10.1038/s43587-022-00170-7,
n8、Essaidi-Laziosi, M., et al., (2021), "Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract", Emerging Microbes & Infections, DOI: 10.1080/22221751.2021.2021806
n美國的PBL Assay Science（又名：Pestka Biomedical Laboratories, Inc.）成立于1990年，創(chuàng)始人Sidney Pestka被稱為“干擾素之父”，PBL Assay Science 作為干擾素和細(xì)胞因子蛋白和抗體以及預(yù)包裝的一流的干擾素和細(xì)胞因子免疫測定試劑盒的高質(zhì)量制造商而享有盛譽(yù)。生產(chǎn)和銷售的高品質(zhì)干擾素產(chǎn)品和生物標(biāo)志物檢測試劑盒在很多高影響力出版物中都有引用，并已在具有挑戰(zhàn)性的樣本中進(jìn)行了外部驗(yàn)證。
- 注意
-
該頁面的中文產(chǎn)品信息的翻譯，僅供參考。準(zhǔn)確的產(chǎn)品信息請以廠家的英文說明書為準(zhǔn)。下單前，請瀏覽說明書確認(rèn)。
-
